Press Releases
Adocia launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet(R)
Adocia SAS, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today the launch of its second clinical trial for the development of HinsBet(R), its fast-acting human insulin. ...
Press Releases
Exclusive NHS Free podcast; Value Based Pricing: Do you get it?
Omar Ali is the Formulary Development Pharmacist for Surrey & Sussex Healthcare NHS Trust and also sits on the External reference Group for Cost Impact Modelling for NICE. eyeforpahrma have been working closely with Omar...
Press Releases
PupPharma moves into the Biocitech science park
Biocitech, the Paris life sciences technology park, announces the arrival of a new resident, PupPharma, which becomes the 27th company to set up shop there. PupPharma moved into the park in May, bringing a further expansion of the range...
Press Releases
Integromics announces winners of proteomics grant competition
Integromics, a market leader in IT solutions for life sciences in the field of genomics and proteomics, today announces the two winners of the Integromics 'Proteomics Mass Spectrometry Research Grant' competition, for the creative use of Integromics' OmicsHub(R) proteomics...
Press Releases
Launch of new CiToxLAB group
CiToxLAB announcement of the new name and logo for the company. The newly established group, created through the merger of CIT and LAB Research, provides a comprehensive range of pre-clinical and specialty services from four facilities in France, Canada,...
Press Releases
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
Novartis today held a groundbreaking ceremony to announce the start of construction of a pharmaceutical manufacturing plant in St. Petersburg, Russia. The construction of this facility represents the most significant Novartis investment in Russia to date. This facility will...
Press Releases
Oroxcell granted good laboratory practice (GLP) certification by Afssaps
Oroxcell, a contract research organization (CRO) specialized in the invention and development of alternative approaches for research establishments and industrial companies, announces that it has been granted good laboratory practice (GLP) certification under the 2004/9/EU directive (safety testing), following...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read